Celltrion unveils the results of phase 2 clinical trials for corona antibody treatment for the first time on the 13th
The world’s first autologous stem cell treatment for degenerative arthritis’Jointstem’ completes the follow-up of a patient in phase 3 clinical trial in Korea. Trinity Medical News
Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”
Daewoong Pharmaceutical’s Hoy Star tablet phase 2a main evaluation variable not satisfied…2b/3 phase progress
![[약업신문]Nature Cell completes all patient follow-up in JointStem Phase 3 clinical trials](http://www.yakup.com/images/common/yakup.jpg "[약업신문]Nature Cell completes all patient follow-up in JointStem Phase 3 clinical trials")
